American Portfolios Advisors - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 254 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2022$1,358,300
+12.4%
20,785
+4.6%
0.06%
+16.0%
Q2 2022$1,208,108
+10.7%
19,880
+14.4%
0.05%
+35.1%
Q1 2022$1,090,880
-8.6%
17,379
+10.4%
0.04%
-7.5%
Q4 2021$1,193,156
-29.2%
15,745
+4.5%
0.04%
-36.5%
Q3 2021$1,685,778
-28.1%
15,061
+4.0%
0.06%
-30.8%
Q2 2021$2,344,005
+29.1%
14,479
-2.8%
0.09%
+15.2%
Q1 2021$1,815,565
-12.6%
14,900
+9.9%
0.08%
-25.5%
Q4 2020$2,076,631
+152.5%
13,563
+37.9%
0.11%
+125.5%
Q3 2020$822,516
+78.0%
9,834
+56.4%
0.05%
+56.7%
Q2 2020$462,179
+164.5%
6,289
+52.6%
0.03%
+100.0%
Q1 2020$174,729
-24.4%
4,120
+8.5%
0.02%
-6.2%
Q4 2019$231,195
+73.2%
3,796
+16.6%
0.02%
+45.5%
Q3 2019$133,463
-10.9%
3,256
+2.3%
0.01%
-15.4%
Q2 2019$149,872
+66.2%
3,182
+26.0%
0.01%
+62.5%
Q1 2019$90,193
-7.8%
2,525
-26.3%
0.01%
-33.3%
Q4 2018$97,852
-30.0%
3,425
+8.7%
0.01%
-25.0%
Q3 2018$139,703
-23.3%
3,150
+1.6%
0.02%
-36.0%
Q2 2018$182,1563,1000.02%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$32,581,00055.55%
NEA Management Company, LLC 1,590,002$103,907,0005.19%
ARK Investment Management 8,237,122$538,296,0003.75%
Nikko Asset Management Americas, Inc. 4,262,736$277,078,0003.54%
CLOUGH CAPITAL PARTNERS L P 414,767$27,105,0002.89%
Integral Health Asset Management, LLC 220,000$14,377,0002.79%
PLUSTICK MANAGEMENT LLC 50,000$3,268,0002.48%
HC Advisors, LLC 53,944$3,525,0002.43%
Green Alpha Advisors, LLC 27,466$1,795,0001.52%
EFG Asset Management (North America) Corp. 84,356$5,516,0001.28%
View complete list of CRISPR THERAPEUTICS AG shareholders